Share-Based Payment Transactions (Details) - shares |
1 Months Ended | 12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
Jun. 14, 2020 |
Nov. 11, 2019 |
Mar. 11, 2019 |
May 27, 2020 |
Jan. 31, 2019 |
Dec. 31, 2020 |
Dec. 31, 2019 |
Dec. 31, 2018 |
|
| Share-Based Payment Transactions (Details) [Line Items] | ||||||||
| Options exercisable to ordinary shares | 3,000,000 | 500,000 | 400,000 | 3,750,000 | 340,000 | |||
| Description of exercise price | exercise price of NIS 0.25 per share (USD 0.07 per share, respectively, based on the exchange rate reported by the Bank of Israel on the same day). | exercise price of NIS 0.28 per share (USD 0.08 per share, respectively, based on the exchange rate reported by the Bank of Israel on December 31, 2019). | exercise price of NIS 2.344 per share (USD 0.68 per share, respectively, based on the exchange rate reported by the Bank of Israel on December 31, 2019). | exercise price of NIS 0.25 per shares (USD 0.06 per share, respectively, based on the exchange rate reported by the Bank of Israel on the same day). | exercise price of NIS 2.344 per shares (USD 0.68 per share, respectively, based on the exchange rate reported by the Bank of Israel on December 31, 2019). | |||
| Grant period | 4 years | 48 months | 48 months | 48 months | 4 years | |||
| Weighted average remaining contractual life | 6 years 357 days | 7 years 339 days | 7 years 233 days | |||||
| Board of directors [Member] | ||||||||
| Share-Based Payment Transactions (Details) [Line Items] | ||||||||
| Options exercisable to ordinary shares | 2,500,000 | |||||||
| Description of exercise price | exercise price of NIS 0.25 per share (USD 0.06 per share, respectively, based on the exchange rate reported by the Bank of Israel on the same day). | |||||||
| Grant period | 4 years | |||||||